Tradestie Institutional Equity Comparison Engine

DCM vs IX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

IX Overall Edge

IX Captures Institutional Edge (3โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ORIX Corporation American Depositary Shares (each representing One (1) Share of Common Stock) (IX) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, DCM trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus IX at 11.8x Forward P/E and 20.5% operating margin (+2.1% YoY). In options structure, DCM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against IX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner IX
DCM N/M vs IX 11.8x Fwd P/E
Growth & Margin Winner IX
Op Margin N/A vs 20.5% ยท YoY N/A vs +2.1%
Momentum & Technical Winner IX
1Y -34.4% vs +24.4% ยท 52W Pos 0% vs 39%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
DCM US Equity
DCM
Institutional Equity
$2.82
-6.62% 1D
Market Cap N/A
1M Return -26.75%
1Y Return -34.42%
Forward P/E N/M
Unified AI Score
48.8 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0
IX NYSE
ORIX Corporation American Depositary Shares (each representing One (1) Share of Common Stock)
Miscellaneous Business Credit Institution
$32.01
-2.91% 1D
Market Cap $35.4B
1M Return -12.83%
1Y Return +24.36%
Forward P/E 11.8x
Unified AI Score
28.0 / 100 SELL
Tech 19.0 Fund 39.0 Flow 50.0 Mom 45.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: DCM -34.42% IX +24.36% Spread: +22.07 pp (IX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
DCM TTM Op. Margin: N/A IX TTM Op. Margin: 20.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DCM vs IX. Trailing 12-month operating profitability (DCM N/A vs IX 20.5%) and valuation multiples (DCM N/M vs IX 11.8x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: DCM (1) vs IX (9)
Institutional Metric DCM IX Criterion Row Winner
Market Capitalization Scale N/A $35.4B Larger Scale IX
Trailing P/E Ratio Valuation N/M 6.0x Lower Multiple IX
Forward P/E Ratio Valuation N/M 11.8x Lower Multiple IX
Revenue Growth (YoY) Growth N/A +2.1% Higher Growth IX
Operating Margin (TTM) Profitability N/A 20.5% Higher Margin IX
Net Profit Margin Profitability N/A 29.7% Higher Margin IX
Return on Equity (ROE) Capital Efficiency N/A 19.7% Higher ROE IX
52-Week Range Position Momentum 0% ($3โ€“$5) 39% ($25โ€“$42) Stronger Trend IX
Beta / 30D Volatility Risk Regime N/A 0.92ฮฒ ยท 27% Vol Lower Realized Risk IX
Unified Institutional Score Composite Signal 48.8 / 100 (HOLD) 28.0 / 100 (SELL) Higher Composite DCM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full DCM vs IX Buy Guide
DCM UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live DCM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
IX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live IX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither DCM nor IX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.